Mangelis Anastasios, Fountoulakis Nikolaos, Corcillo Antonella, Collins Julian, Vas Prashant, Hussain Sufyan, Hopkins David, Gnudi Luigi, Thomas Stephen, Ayis Salma, Karalliedde Janaka
School of Population Health and Environmental Sciences, King's College London, London, U.K.
King's Health Partners and School of Cardiovascular Medicine and Sciences, King's College London, London, U.K.
Diabetes Care. 2022 Sep 1;45(9):2095-2102. doi: 10.2337/dc22-0815.
The aim of the study was to identify the demographic and clinical features in an urban cohort of people with type 1 diabetes who developed a ≥50% decline in estimated glomerular filtration rate (eGFR).
We evaluated 5,261 people with type 1 diabetes (51% female, 13.4% African Caribbean) with baseline eGFR >45 mL/min/1.73 m2 between 2004 and 2018. The primary end point was an eGFR decline of ≥50% from baseline with a final eGFR <30 mL/min/1.73 m2. eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation.
Of the cohort, 263 (5%) reached the primary end point. These individuals were more likely to be of African Caribbean ethnicity, be older, have a longer duration of diabetes, have higher systolic blood pressure and HbA1c, have more prevalent retinopathy, and have higher albuminuria (all P < 0.05). In multivariable Cox regression models, African Caribbean ethnicity emerged as a significant risk factor for the primary end point (hazard ratio 1.57, 95% CI 1.19, 2.08) compared with other ethnicities and independent of established risk factors (P < 0.01). The incidence rate for the primary end point in African Caribbean people was double that in non-African Caribbean people (16 vs. 7.7 per 1000 patient-years, P < 0.001). A similar significant independent impact of African Caribbean ethnicity for secondary end points (≥40% and ≥30% fall in eGFR) was observed.
We report a novel observation that African Caribbean ethnicity increased the risk of kidney function loss in people with type 1 diabetes, an effect that was independent of traditional risk factors. Further studies are needed to examine the associated pathophysiology that may explain this observation.
本研究旨在确定1型糖尿病城市队列中估算肾小球滤过率(eGFR)下降≥50%的人群的人口统计学和临床特征。
我们评估了2004年至2018年间5261例1型糖尿病患者(51%为女性,13.4%为非洲裔加勒比人),其基线eGFR>45 mL/min/1.73 m²。主要终点是eGFR较基线下降≥50%且最终eGFR<30 mL/min/1.73 m²。使用慢性肾脏病流行病学合作组方程计算eGFR。
在该队列中,263例(5%)达到主要终点。这些个体更可能为非洲裔加勒比人、年龄较大、糖尿病病程较长、收缩压和糖化血红蛋白(HbA1c)较高、视网膜病变更普遍且蛋白尿水平较高(所有P<0.05)。在多变量Cox回归模型中,与其他种族相比,非洲裔加勒比人种族是主要终点的显著危险因素(风险比1.57,95%CI 1.19,2.08),且独立于已确定的危险因素(P<0.01)。非洲裔加勒比人主要终点的发病率是非非洲裔加勒比人的两倍(每1000患者年16例对7.7例,P<0.001)。观察到非洲裔加勒比人种族对次要终点(eGFR下降≥40%和≥30%)有类似的显著独立影响。
我们报告了一项新的观察结果,即非洲裔加勒比人种族增加了1型糖尿病患者肾功能丧失的风险,这一效应独立于传统危险因素。需要进一步研究来探讨可能解释这一观察结果的相关病理生理学。